Want to join the conversation?
$ALXN's net product sales for FY15 grew by 17% from last year. The increase was primarily due to rise in unit volumes of 29% due to increased demand globally for Soliris therapy for patients with PNH or aHUS during the respective periods. The positive impact of volume on net product sales was offset by negative impact on foreign exchange of 8%.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!
$SGY is expected to achieve $6.17 price target in next year, with a minimum target of $3.00, due to the price increase of 27.85% to $6.29 during the last trading session.